These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28619426)

  • 1. Hospitalization is associated with subsequent disability in multiple sclerosis.
    Garland A; Metz LM; Bernstein CN; Peschken CA; Hitchon CA; Marrie RA
    Mult Scler Relat Disord; 2017 May; 14():23-28. PubMed ID: 28619426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.
    Beiki O; Frumento P; Bottai M; Manouchehrinia A; Hillert J
    JAMA Neurol; 2019 Jun; 76(6):665-671. PubMed ID: 30882868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric comorbidity is associated with disability progression in multiple sclerosis.
    McKay KA; Tremlett H; Fisk JD; Zhang T; Patten SB; Kastrukoff L; Campbell T; Marrie RA;
    Neurology; 2018 Apr; 90(15):e1316-e1323. PubMed ID: 29523642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of physical comorbidities on disability progression in multiple sclerosis.
    Zhang T; Tremlett H; Zhu F; Kingwell E; Fisk JD; Bhan V; Campbell T; Stadnyk K; Carruthers R; Wolfson C; Warren S; Marrie RA;
    Neurology; 2018 Jan; 90(5):e419-e427. PubMed ID: 29298855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disability progression in multiple sclerosis is slower than previously reported.
    Tremlett H; Paty D; Devonshire V
    Neurology; 2006 Jan; 66(2):172-7. PubMed ID: 16434648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
    Sayao AL; Devonshire V; Tremlett H
    Neurology; 2007 Feb; 68(7):496-500. PubMed ID: 17296915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study.
    Kopp TI; Blinkenberg M; Petersen T; Sorensen PS; Magyari M
    Mult Scler Relat Disord; 2020 May; 40():101956. PubMed ID: 32007654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands.
    Karampampa K; Gustavsson A; van Munster ET; Hupperts RM; Sanders EA; Mostert J; Sinnige OL; de Graaf J; Pop P; Miltenburger C; Groot MT; Relleke M; van der Hel WS
    J Med Econ; 2013 Jul; 16(7):939-50. PubMed ID: 23692584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
    Martinez-Lapiscina EH; Arnow S; Wilson JA; Saidha S; Preiningerova JL; Oberwahrenbrock T; Brandt AU; Pablo LE; Guerrieri S; Gonzalez I; Outteryck O; Mueller AK; Albrecht P; Chan W; Lukas S; Balk LJ; Fraser C; Frederiksen JL; Resto J; Frohman T; Cordano C; Zubizarreta I; Andorra M; Sanchez-Dalmau B; Saiz A; Bermel R; Klistorner A; Petzold A; Schippling S; Costello F; Aktas O; Vermersch P; Oreja-Guevara C; Comi G; Leocani L; Garcia-Martin E; Paul F; Havrdova E; Frohman E; Balcer LJ; Green AJ; Calabresi PA; Villoslada P;
    Lancet Neurol; 2016 May; 15(6):574-84. PubMed ID: 27011339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
    He A; Merkel B; Brown JWL; Zhovits Ryerson L; Kister I; Malpas CB; Sharmin S; Horakova D; Kubala Havrdova E; Spelman T; Izquierdo G; Eichau S; Trojano M; Lugaresi A; Hupperts R; Sola P; Ferraro D; Lycke J; Grand'Maison F; Prat A; Girard M; Duquette P; Larochelle C; Svenningsson A; Petersen T; Grammond P; Granella F; Van Pesch V; Bergamaschi R; McGuigan C; Coles A; Hillert J; Piehl F; Butzkueven H; Kalincik T;
    Lancet Neurol; 2020 Apr; 19(4):307-316. PubMed ID: 32199096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disability profile of MS did not change over 10 years in a population-based prevalence cohort.
    Pittock SJ; Mayr WT; McClelland RL; Jorgensen NW; Weigand SD; Noseworthy JH; Rodriguez M
    Neurology; 2004 Feb; 62(4):601-6. PubMed ID: 14981177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic status and disability progression in multiple sclerosis: A multinational study.
    Harding KE; Wardle M; Carruthers R; Robertson N; Zhu F; Kingwell E; Tremlett H
    Neurology; 2019 Mar; 92(13):e1497-e1506. PubMed ID: 30796140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course of multiple sclerosis: A nationwide cohort study.
    Manouchehrinia A; Beiki O; Hillert J
    Mult Scler; 2017 Oct; 23(11):1488-1495. PubMed ID: 27956559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.
    Rabadi MH; Vincent AS
    Disabil Rehabil; 2013; 35(22):1877-84. PubMed ID: 23600712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?
    Sidhom Y; Damak M; Riahi A; Hizem Y; Mrissa R; Mhiri C; Gouider R
    J Neurol Sci; 2014 Aug; 343(1-2):110-4. PubMed ID: 24980939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US.
    Jones E; Pike J; Marshall T; Ye X
    BMC Health Serv Res; 2016 Jul; 16():294. PubMed ID: 27443278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early clinical markers of aggressive multiple sclerosis.
    Malpas CB; Manouchehrinia A; Sharmin S; Roos I; Horakova D; Havrdova EK; Trojano M; Izquierdo G; Eichau S; Bergamaschi R; Sola P; Ferraro D; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Grand'Maison F; Ozakbas S; Van Pesch V; Granella F; Hupperts R; Pucci E; Boz C; Sidhom Y; Gouider R; Spitaleri D; Soysal A; Petersen T; Verheul F; Karabudak R; Turkoglu R; Ramo-Tello C; Terzi M; Cristiano E; Slee M; McCombe P; Macdonell R; Fragoso Y; Olascoaga J; Altintas A; Olsson T; Butzkueven H; Hillert J; Kalincik T
    Brain; 2020 May; 143(5):1400-1413. PubMed ID: 32386427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time between expanded disability status scale (EDSS) scores.
    Zurawski J; Glanz BI; Chua A; Lokhande H; Rotstein D; Weiner H; Engler D; Chitnis T; Healy BC
    Mult Scler Relat Disord; 2019 May; 30():98-103. PubMed ID: 30763908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported levels of education and disability progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Van Remoortel A; De Keyser J; Nagels G
    Acta Neurol Scand; 2016 Dec; 134(6):414-419. PubMed ID: 27761897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.